ID   A2780-SCA
AC   CVCL_DI16
DR   cancercelllines; CVCL_DI16
DR   GEO; GSM459649
DR   GEO; GSM459730
DR   Progenetix; CVCL_DI16
DR   Wikidata; Q54606579
RX   PubMed=12509269;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 10
//
RX   PubMed=12509269; DOI=10.1016/S1568-7864(02)00187-8;
RA   Massey A., Offman J., Macpherson P., Karran P.;
RT   "DNA mismatch repair and acquired cisplatin resistance in E. coli and
RT   human ovarian carcinoma cells.";
RL   DNA Repair 2:73-89(2003).
//